Division of Microbiology, Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Post Box: 76169-133, Kerman, 7616914111, Iran.
Division of Poultry Diseases, Department of Clinical Science, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran.
BMC Vet Res. 2023 Jan 19;19(1):13. doi: 10.1186/s12917-023-03566-8.
Clostridium perfringens (C. perfringens) is a serious anaerobic enteric pathogen causing necrotic enteritis (NE) in broiler chickens. Following the ban on antibiotics as growth promoters in animal feedstuffs, there has been a remarkable rise in occurrence of NE which resulted in considering alternative approaches, particularly vaccination. The objective of this work was to evaluate the recombinant Lactobacillus casei (L. casei) expressing the C-terminal domain of α-toxin from C. perfringens as a potential probiotic-based vaccine candidate to immunize the broiler chickens against NE.
The broiler chickens immunized orally with recombinant vaccine strain were significantly protected against experimental NE challenge, and developed specific serum anti-α antibodies. Additionally, the immunized birds showed higher body weight gains compared with control groups during the challenge experiment.
The current study showed that oral immunization of broiler chickens with a safe probiotic-based vector vaccine expressing α-toxin from C. perfringens could provide protective immunity against NE in birds.
产气荚膜梭菌(C. perfringens)是一种严重的厌氧肠道病原体,可导致肉鸡坏死性肠炎(NE)。在禁止抗生素作为动物饲料中的生长促进剂后,NE 的发生率显著上升,因此考虑了替代方法,特别是疫苗接种。本工作的目的是评估表达产气荚膜梭菌α-毒素 C 末端结构域的重组干酪乳杆菌(L. casei)作为一种潜在的益生菌基疫苗候选物,以免疫肉鸡抵抗 NE。
经口服免疫重组疫苗株的肉鸡对实验性 NE 攻毒具有显著的保护作用,并产生了特异性的血清抗-α 抗体。此外,在攻毒实验期间,免疫组的鸡只体重增长高于对照组。
本研究表明,口服免疫表达产气荚膜梭菌α-毒素的安全益生菌载体疫苗可在禽类中提供针对 NE 的保护性免疫。